Synta completes direct public offering

Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass. Business: Cancer, Autoimmune Date completed: 7/26/12 Type: Direct public offering Raised: $25.8 million Shares: 4 million Price: $6.49 Share...